2 news items
AbbVie To Acquire Landos Biopharma At A Price Of $20.42 Per Share In Cash Upon Closing, Or ~$137.5M
ABBV
LABP
25 Mar 24
."This announcement is a testament to Landos' talented team and their commitment to our mission of creating oral treatments that can address a therapeutic
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
ABBV
LABP
25 Mar 24
, AbbVie. "This announcement is a testament to Landos' talented team and their commitment to our mission of creating oral treatments that can
- Prev
- 1
- Next